Bank Ina Perdana Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank Ina Perdana Tbk trades at Rp3,750 (market cap 22.9T, 269.4K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 164.65B, 214.9K 24h volume). The key difference: Bank Ina Perdana Tbk is far larger — about 139.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bank Ina Perdana Tbk is more actively traded (269.4K versus 214.9K). Which is the better fit depends on your goals.
| BINA | OBAT | |
|---|---|---|
Market Cap | 22.9T | 164.65B |
Volume | 269.4K | 214.9K |
Lot | 2.69K | 2.15K |
Turnover | 996.02M | 51.97M |
Average Price | 3,697.16 | 241.85 |
Value | 996.02M | 51.97M |
Indicative Equilibrium Price | 3,750 | 240 |
Indicative Equilibrium Volume | 1K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank Ina Perdana Tbk (the Bank) was established in Jakarta based on Notarial Deed No. 32 of Winnie Hadiprodjo Public Notary in Jakarta dated February 09, 1990. The Company started its commercial operations on July 1991.
Read more on BINA →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →